Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract
- ByInvesting.com-
Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases,...